BRPI0922653B8 - uso de uma lipase bacteriana do tipo pseudomonas em solução aquosa - Google Patents

uso de uma lipase bacteriana do tipo pseudomonas em solução aquosa

Info

Publication number
BRPI0922653B8
BRPI0922653B8 BRPI0922653A BRPI0922653A BRPI0922653B8 BR PI0922653 B8 BRPI0922653 B8 BR PI0922653B8 BR PI0922653 A BRPI0922653 A BR PI0922653A BR PI0922653 A BRPI0922653 A BR PI0922653A BR PI0922653 B8 BRPI0922653 B8 BR PI0922653B8
Authority
BR
Brazil
Prior art keywords
aqueous solution
bacterial lipase
pseudomonas bacterial
pseudomonas
lipase
Prior art date
Application number
BRPI0922653A
Other languages
English (en)
Inventor
Rämsch Christian
Kurfürst Manfred
Friedrich Olaf
Friedel Rainer
Hüttler Silke
Original Assignee
Nordmark Arzneimittel Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordmark Arzneimittel Gmbh & Co Kg filed Critical Nordmark Arzneimittel Gmbh & Co Kg
Publication of BRPI0922653A2 publication Critical patent/BRPI0922653A2/pt
Publication of BRPI0922653B1 publication Critical patent/BRPI0922653B1/pt
Publication of BRPI0922653B8 publication Critical patent/BRPI0922653B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes

Abstract

preparação farmacêutica. a presente invenção refere-se a uma preparação farmacêutica para o tratamento de insuficiência pancreática compreendendo uma forma líquida de administração de enzimas.
BRPI0922653A 2009-01-29 2009-01-29 uso de uma lipase bacteriana do tipo pseudomonas em solução aquosa BRPI0922653B8 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2009/000566 WO2010085975A1 (de) 2009-01-29 2009-01-29 Pharmazeutisches präparat enthaltend lipase bakteriellen ursprungs

Publications (3)

Publication Number Publication Date
BRPI0922653A2 BRPI0922653A2 (pt) 2016-01-05
BRPI0922653B1 BRPI0922653B1 (pt) 2021-04-13
BRPI0922653B8 true BRPI0922653B8 (pt) 2021-05-25

Family

ID=41091375

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0922653A BRPI0922653B8 (pt) 2009-01-29 2009-01-29 uso de uma lipase bacteriana do tipo pseudomonas em solução aquosa

Country Status (13)

Country Link
US (2) US20110293590A1 (pt)
EP (2) EP2391382B1 (pt)
JP (1) JP5970189B2 (pt)
CN (1) CN102231988A (pt)
BR (1) BRPI0922653B8 (pt)
CY (1) CY1115519T1 (pt)
DK (1) DK2391382T3 (pt)
ES (1) ES2488407T3 (pt)
HR (1) HRP20140715T1 (pt)
PL (1) PL2391382T3 (pt)
PT (1) PT2391382E (pt)
SI (1) SI2391382T1 (pt)
WO (1) WO2010085975A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2165717A1 (de) 2008-08-27 2010-03-24 Nordmark Arzneimittel GmbH & Co.KG Verfahren zur Verringerung der viralen und mikrobiellen Belastung feststoffhaltiger biologischer Extrakte
PL2295039T5 (pl) 2009-08-28 2023-02-27 Nordmark Pharma Gmbh Sposób wytwarzania granulek zawierających pankreatynę, w szczególności mikrogranulek zawierających pankreatynę, oraz wytworzone tym sposobem granulki zawierające pankreatynę
EP2489349B1 (de) 2011-02-17 2014-05-28 Nordmark Arzneimittel GmbH & Co.KG Pankreatin-Pellets, insbesondere Pankreatin-Mikropellets, und Verfahren zu deren Herstellung
US8268305B1 (en) 2011-09-23 2012-09-18 Bio-Cat, Inc. Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
WO2013146529A1 (ja) * 2012-03-28 2013-10-03 不二製油株式会社 ランダムエステル交換油脂の製造方法
DE102015114857A1 (de) 2015-09-04 2017-03-09 Nordmark Arzneimittel Gmbh & Co. Kg Getränk, enthaltend eine pharmazeutische Zusammensetzung
DE102017104482A1 (de) * 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Pharmazeutische Zusammensetzung umfassend Pankreatin und einen lipasehaltigen Überzug
DE102017104501A1 (de) 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Pharmazeutische Zusammensetzung umfassend einen Träger und einen Überzug enthaltend wenigstens eine Lipase
DE102017104480A1 (de) * 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Wässrige Lösung von Burlulipase umfassend Kalziumionen
DE102017104472A1 (de) 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Schmelztablette enthaltend Burlulipase und daraus hergestellte pharmazeutische Zusammensetzung

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2189948A (en) 1938-10-31 1940-02-13 Griffith Laboratories Sterilization of pancreatin
DE2923279B1 (de) 1979-06-08 1980-11-20 Kali Chemie Pharma Gmbh Verfahren zur Herstellung von Pankreatin-Pellets
US5063160A (en) * 1989-03-16 1991-11-05 Olin Corporation Identification, characterization, and method of production of a novel microbial lipase
CA2030581C (en) 1989-11-24 2000-06-27 Gunther Atzl Pancreatin preparations
DK173590D0 (da) 1990-06-06 1990-07-19 Novo Nordisk As Rekombinante terapeutiske lipaser
ATE175117T1 (de) * 1991-07-01 1999-01-15 Basf Ag Verwendung von lipasen zur herstellung von arzneimitteln
DE4227385A1 (de) 1992-08-19 1994-02-24 Kali Chemie Pharma Gmbh Pankreatinmikropellets
JPH08143469A (ja) * 1994-11-14 1996-06-04 Amano Pharmaceut Co Ltd 膵外分泌機能不全症治療剤
DE19724845A1 (de) 1996-08-28 1998-03-05 Solvay Pharm Gmbh Verwendung von komplexen Lipiden als stabilisierende Zusätze zu pharmazeutischen Zubereitungen von Verdauungsenzymgemischen
US6270723B1 (en) 1998-06-15 2001-08-07 Bbi Bioseq, Inc. Rapid cryobaric sterilization and vaccine preparation
US20010046493A1 (en) * 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
KR100518139B1 (ko) 2000-04-06 2005-10-04 한나 리서치 인스티튜트 단백질 안정화된 유제
AT502588B1 (de) * 2002-11-26 2010-05-15 Brenner Franz Papaya-mus
EP1486415A1 (en) 2003-06-12 2004-12-15 SSP Technology A/S Wind turbine blade and method of manufacturing a blade root
US6908789B1 (en) 2003-12-15 2005-06-21 Intel Corporation Method of making a microelectronic assembly
CA2560613C (en) * 2004-03-22 2015-11-24 Solvay Pharmaceuticals Gmbh Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
US7718169B2 (en) * 2004-10-14 2010-05-18 Cystic Fibrosis Foundations Therapeutics, Inc. Compositions and methods for treating pancreatic insufficiency
DE102004056340B4 (de) 2004-11-22 2010-11-18 Repower Systems Ag Vorrichtung und Verfahren zur Montage und/oder Demontage eines Bauteils einer Windkraftanlage
DE102005014868A1 (de) 2005-03-30 2006-10-05 Repower Systems Ag Offshore-Windenergieanlage mit rutschfesten Füßen
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
DE102006021982C5 (de) 2006-05-10 2010-10-07 Repower Systems Ag Gestaffelt abschaltbarer Windpark
CA2677989C (en) * 2007-02-20 2018-04-24 Eurand Pharmaceuticals Limited Stable digestive enzyme compositions
DE102007014863A1 (de) 2007-03-26 2008-10-02 Repower Systems Ag Verfahren zum Betreiben einer Windenergieanlage
AU2008239737A1 (en) 2007-04-13 2008-10-23 Beth Israel Deaconess Medical Center, Inc. Novel nutritional food products for improved digestion and intestinal absorption
DE102008012664A1 (de) 2008-01-30 2009-08-06 Repower Systems Ag Windenergieanlage und ein Turm oder Turmsegment und eine Türzarge dafür
EP2165717A1 (de) 2008-08-27 2010-03-24 Nordmark Arzneimittel GmbH & Co.KG Verfahren zur Verringerung der viralen und mikrobiellen Belastung feststoffhaltiger biologischer Extrakte
PL2295039T5 (pl) 2009-08-28 2023-02-27 Nordmark Pharma Gmbh Sposób wytwarzania granulek zawierających pankreatynę, w szczególności mikrogranulek zawierających pankreatynę, oraz wytworzone tym sposobem granulki zawierające pankreatynę
EP2489349B1 (de) 2011-02-17 2014-05-28 Nordmark Arzneimittel GmbH & Co.KG Pankreatin-Pellets, insbesondere Pankreatin-Mikropellets, und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
PT2391382E (pt) 2014-08-22
JP5970189B2 (ja) 2016-08-17
US10596235B2 (en) 2020-03-24
WO2010085975A1 (de) 2010-08-05
DK2391382T3 (da) 2014-08-25
EP2391382A1 (de) 2011-12-07
BRPI0922653A2 (pt) 2016-01-05
EP2786761A1 (de) 2014-10-08
BRPI0922653B1 (pt) 2021-04-13
EP2391382B1 (de) 2014-06-04
SI2391382T1 (sl) 2014-10-30
US20160287679A1 (en) 2016-10-06
US20110293590A1 (en) 2011-12-01
JP2012516289A (ja) 2012-07-19
HRP20140715T1 (hr) 2014-09-26
CN102231988A (zh) 2011-11-02
ES2488407T3 (es) 2014-08-27
PL2391382T3 (pl) 2014-11-28
CY1115519T1 (el) 2017-01-04

Similar Documents

Publication Publication Date Title
BRPI0922653B8 (pt) uso de uma lipase bacteriana do tipo pseudomonas em solução aquosa
BR112012004377A2 (pt) terapia de reposição enzimática com progressão de dose para tratamento de deficiência de esfingomielinase ácida.
HN2011002037A (es) Dicianopiridinas alquilamino-sustituidas y sus profarmacos de ester de aminoacido
BR112014009418A2 (pt) macrociclos peptidomiméticos
GT201400033A (es) Pirimidinas anilladas sustituidas y uso de las mismas
CL2011002818A1 (es) Composicion de leche para el crecimiento que comprende microorganismos probioticos; uso de dicha composicion para preparar medicamento util para prevenir o tratar trastornos inflamatorios.
TN2012000280A1 (en) Methods of administering pirfenidone therapy
EA201400119A1 (ru) Фармацевтическая композиция, способы лечения и их применение
ECSP11011276A (es) Composición farmacéutica, forma farmacéutica, procedimiento para su preparación, métodos de tratamiento y usos de la misma.
AR081681A1 (es) METODOS Y COMPOSICIONES PARA LA ADMINISTRACION INTRATECAL DE b-GALACTOCEREBROSIDASA
CL2013001947A1 (es) Composicion farmaceutica que comprende pioglitazona; uso de pioglitazona para tratar alzheimer; composicion que comprende pioglitazona.
AU2018256561A1 (en) Aminosteroids for the treatment of a PTP1B associated disease
CO6710913A2 (es) Uso de ácido lipasa lisosomal para tratar la deficiencia de ácido lipasa lisosomal en pacientes
MX356728B (es) Combinación farmacéutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2.
MX349224B (es) Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa.
AR082943A1 (es) Formula nutricional predigerida
CO7160080A2 (es) Composiciones lipídicas de racecadotrillo
BRPI0912687A2 (pt) uso de bactéria probiótica para o tratamento de hiperhomocisteinaemia
WO2012103523A3 (en) Novel modulators of development of adipocyte and cancer cells
MX2014001368A (es) Soluciones anti-inflamatorias estables para inyección.
BR112014011481A2 (pt) hidrolisado de colágeno e seu uso
CL2010001577A1 (es) Uso de nifurtimox para preparar un medicamento util en el tratamiento de enfermedades causadas por giardias.
EA201490041A1 (ru) Пластырь, содержащий диклофенак и тиоколхикозид
MY160753A (en) Pharmaceutical composition in the form of an oral suspension comprising a flavonoid fraction and xanthan gum
IN2014DN03010A (pt)

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/01/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME MEDIDA CAUTELAR DE 07/04/2021 - ADI 5.529/DF

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/01/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B25D Requested change of name of applicant approved

Owner name: NORDMARK ARZNEIMITTEL HOLDING GMBH AND CO. KG (DE)

B25A Requested transfer of rights approved

Owner name: NORDMARK PHARMA GMBH (DE)